Lab News
Liquid biopsy boosts the odds in triple-negative breast cancer
December 13, 2019 -- Circulating tumor DNA test results were significantly associated with disease-free survival in women with early triple-negative breast cancer in a phase II study presented on December 13 at the San Antonio Breast Cancer Symposium.
Discuss
December 13, 2019 -- Circulating tumor DNA test results were significantly associated with disease-free survival in women with early triple-negative breast cancer in a phase II study presented on December 13 at the San Antonio Breast Cancer Symposium.
Discuss Genetics group makes case against testing all with breast cancer
December 13, 2019 -- The American College of Medical Genetics and Genomics (ACMG) highlighted the lack of evidence for universal testing of breast cancer patients for BRCA1/2 mutations -- specifically or as part of multigene panels -- in a statement published December 13 in its journal Genetics in Medicine.
Discuss
December 13, 2019 -- The American College of Medical Genetics and Genomics (ACMG) highlighted the lack of evidence for universal testing of breast cancer patients for BRCA1/2 mutations -- specifically or as part of multigene panels -- in a statement published December 13 in its journal Genetics in Medicine.
Discuss CVS Health paves way for genetic testing of cancer patients
December 12, 2019 -- CVS Health is launching a program that will facilitate genetic testing for cancer patients at the point of prescribing to guide personalized treatment for members of its Aetna subsidiary and other insurance companies.
Discuss
December 12, 2019 -- CVS Health is launching a program that will facilitate genetic testing for cancer patients at the point of prescribing to guide personalized treatment for members of its Aetna subsidiary and other insurance companies.
Discuss Agendia's MammaPrint refines risk scoring in younger cancer patients
December 12, 2019 -- Agendia's MammaPrint 70-gene panel can be used to refine risk in patients 50 years of age and younger with early breast cancer, which may be helpful in guiding some to less-intensive treatment regimens, according to a poster study presented by the company at the San Antonio Breast Cancer Symposium.
Discuss
December 12, 2019 -- Agendia's MammaPrint 70-gene panel can be used to refine risk in patients 50 years of age and younger with early breast cancer, which may be helpful in guiding some to less-intensive treatment regimens, according to a poster study presented by the company at the San Antonio Breast Cancer Symposium.
Discuss Pathologists get to the bottom of AML subtypes
December 12, 2019 -- Whole genome and transcriptome sequencing enabled more precise assessment of acute myeloid leukemia (AML) and myelodysplastic syndromes, shedding light on their true genetic natures, in a new study presented at the American Society of Hematology annual meeting in Orlando, FL.
Discuss
December 12, 2019 -- Whole genome and transcriptome sequencing enabled more precise assessment of acute myeloid leukemia (AML) and myelodysplastic syndromes, shedding light on their true genetic natures, in a new study presented at the American Society of Hematology annual meeting in Orlando, FL.
Discuss Inflammatory marker sCD14 lurks in dementia
December 11, 2019 -- Higher circulating levels of the inflammatory biomarker plasma soluble CD14 (sCD14) were associated with brain atrophy and dementia in an analysis of data from two observational heart health studies. The association was reported on December 9 in the journal Neurology.
Discuss
December 11, 2019 -- Higher circulating levels of the inflammatory biomarker plasma soluble CD14 (sCD14) were associated with brain atrophy and dementia in an analysis of data from two observational heart health studies. The association was reported on December 9 in the journal Neurology.
Discuss Testing for BPA safety comes under the microscope
December 10, 2019 -- Accepted testing for bisphenol A (BPA) in urine underestimates the chemical's levels in humans, and a new method provides a more accurate and concerning picture, researchers claim in a report published in Lancet Diabetes & Endocrinology on December 5.
Discuss
December 10, 2019 -- Accepted testing for bisphenol A (BPA) in urine underestimates the chemical's levels in humans, and a new method provides a more accurate and concerning picture, researchers claim in a report published in Lancet Diabetes & Endocrinology on December 5.
Discuss Study finds room for improvement in youth HCV screening
December 10, 2019 -- There is room for improvement in screening and treatment for hepatitis C virus (HCV) infection in at-risk youths ages 13 to 21, according to a large study of U.S. federally qualified health centers published as a research letter in the Journal of the American Medical Association on December 10.
Discuss
December 10, 2019 -- There is room for improvement in screening and treatment for hepatitis C virus (HCV) infection in at-risk youths ages 13 to 21, according to a large study of U.S. federally qualified health centers published as a research letter in the Journal of the American Medical Association on December 10.
Discuss Startup develops POC diagnostic for tuberculosis
December 9, 2019 -- Diascopic, a Cleveland-based diagnostic technology startup, is using a grant from the U.S. Small Business Innovation Research program to develop a near point-of-care (POC) diagnostic platform for detecting the bacterium that causes tuberculosis.
Discuss
December 9, 2019 -- Diascopic, a Cleveland-based diagnostic technology startup, is using a grant from the U.S. Small Business Innovation Research program to develop a near point-of-care (POC) diagnostic platform for detecting the bacterium that causes tuberculosis.
Discuss U.K. vitamin D study feeds into global debates on appropriate use
December 5, 2019 -- Prescriptions for vitamin D to U.K. children have risen dramatically over the years, and medical records suggest inappropriate use, according to a study published online December 3 in BMJ Open. The results feed into international debates about overuse and the high costs of supplementation and testing.
Discuss
December 5, 2019 -- Prescriptions for vitamin D to U.K. children have risen dramatically over the years, and medical records suggest inappropriate use, according to a study published online December 3 in BMJ Open. The results feed into international debates about overuse and the high costs of supplementation and testing.
Discuss
News in Brief
Conferences
Precision Medicine World Conference (PMWC) 2020
January 21-24, 2020
Santa Clara, California United States
January 21-24, 2020
Santa Clara, California United States
Society for Laboratory Automation and Screening (SLAS) 2020
January 25-29, 2020
San Diego, California United States
January 25-29, 2020
San Diego, California United States
American Society for Microbiology (ASM) Biothreats
January 28-30, 2020
Arlington, Virginia United States
January 28-30, 2020
Arlington, Virginia United States
Festival of Genomics 2020
January 29-30, 2020
London, Greater London United Kingdom
January 29-30, 2020
London, Greater London United Kingdom
Medlab Middle East
February 3-6, 2020
Dubai, Dubai United Arab Emirates
February 3-6, 2020
Dubai, Dubai United Arab Emirates
Connect
Latest Tweets